• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童-青少年多发性硬化症:临床特征与治疗

Childhood-juvenile multiple sclerosis: clinical characteristics and treatment.

作者信息

Ghezzi Angelo

机构信息

Ospedale di Gallarate, Centro Studi Sclerosi Multipla, via Pastori 4, 21013 Gallarate, Italy.

出版信息

Expert Rev Neurother. 2005 May;5(3):403-11. doi: 10.1586/14737175.5.3.403.

DOI:10.1586/14737175.5.3.403
PMID:15938673
Abstract

The characteristics of multiple sclerosis with onset during childhood or adolescence are presented in this review. The clinical findings are similar to those of the adult form, but some aspects are peculiar: the high female to male ratio, occurrence of hyperacute forms, occurrence of encephalopatic symptoms and high relapse rate. The evolution is relapsing-progressive in most cases. Mild and severe disability are reached after a longer interval than in the adult form but, in spite of this, at a given age disability is higher. A high relapse rate, short interval between first and second attack and high disability after the first year are negative prognostic factors. Magnetic resonance imaging and cerebrospinal fluid data are discussed, with particular reference to differential diagnosis from acute disseminated encephalomyelitis. Currently, there are no controlled trials concerning subjects aged under 16 years. Some observations demonstrate that immunomodulatory drugs are well tolerated and have a beneficial effect, reducing the relapse rate and progression of the disease.

摘要

本综述介绍了儿童期或青少年期起病的多发性硬化症的特征。临床发现与成人型相似,但有些方面较为特殊:女性与男性比例高、超急性形式的出现、脑病症状的出现以及高复发率。在大多数情况下,病情演变呈复发-进展型。与成人型相比,达到轻度和重度残疾的间隔时间更长,但尽管如此,在特定年龄时残疾程度更高。高复发率、首次发作与第二次发作之间的间隔时间短以及第一年之后的高残疾率都是不良预后因素。文中讨论了磁共振成像和脑脊液数据,特别提及与急性播散性脑脊髓炎的鉴别诊断。目前,尚无针对16岁以下受试者的对照试验。一些观察结果表明,免疫调节药物耐受性良好且具有有益作用,可降低疾病的复发率和进展。

相似文献

1
Childhood-juvenile multiple sclerosis: clinical characteristics and treatment.儿童-青少年多发性硬化症:临床特征与治疗
Expert Rev Neurother. 2005 May;5(3):403-11. doi: 10.1586/14737175.5.3.403.
2
Natural history of multiple sclerosis: a unifying concept.多发性硬化症的自然史:一个统一的概念。
Brain. 2006 Mar;129(Pt 3):606-16. doi: 10.1093/brain/awl007. Epub 2006 Jan 16.
3
First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability.儿童期急性中枢神经系统炎性脱髓鞘首发:多发性硬化和残疾的预后因素
J Pediatr. 2004 Feb;144(2):246-52. doi: 10.1016/j.jpeds.2003.10.056.
4
Predictors of relapse rate in MS clinical trials.多发性硬化症临床试验中复发率的预测因素。
Neurology. 2005 Dec 13;65(11):1769-73. doi: 10.1212/01.wnl.0000187122.71735.1f.
5
Multiple sclerosis in Australia: prognostic factors.澳大利亚的多发性硬化症:预后因素。
J Clin Neurosci. 2000 Jan;7(1):16-9. doi: 10.1054/jocn.1998.0107.
6
Natalizumab treatment in pediatric multiple sclerosis: a case report.那他珠单抗治疗儿童多发性硬化症:一例报告
Eur J Paediatr Neurol. 2009 Jan;13(1):67-71. doi: 10.1016/j.ejpn.2008.01.007. Epub 2008 Apr 11.
7
Multiphasic acute disseminated encephalomyelitis or pediatric multiple sclerosis: report of an atypical case.多相性急性播散性脑脊髓炎或儿童多发性硬化症:1例非典型病例报告。
J Child Neurol. 2009 Feb;24(2):241-6. doi: 10.1177/0883073808324543.
8
[Multiple sclerosis in children].
Ned Tijdschr Geneeskd. 2007 Jun 30;151(26):1464-8.
9
Pediatric multiple sclerosis.小儿多发性硬化症
J Child Neurol. 2012 Nov;27(11):1378-83. doi: 10.1177/0883073812452784. Epub 2012 Aug 21.
10
Prognostic factors for early severity in a childhood multiple sclerosis cohort.儿童多发性硬化症队列中早期严重程度的预后因素。
Pediatrics. 2006 Sep;118(3):1133-9. doi: 10.1542/peds.2006-0655.

引用本文的文献

1
Impact of menopause on relapse rate and disability level in patients with multiple sclerosis (MS): a systematic review and meta-analysis.绝经对多发性硬化症(MS)患者复发率和残疾程度的影响:系统评价和荟萃分析。
BMC Neurol. 2023 Sep 4;23(1):316. doi: 10.1186/s12883-023-03332-1.
2
Effect of Dimethyl Fumarate vs Interferon β-1a in Patients With Pediatric-Onset Multiple Sclerosis: The CONNECT Randomized Clinical Trial.富马酸二甲酯与干扰素β-1a 治疗儿童发病多发性硬化症的效果比较:CONNECT 随机临床试验。
JAMA Netw Open. 2022 Sep 1;5(9):e2230439. doi: 10.1001/jamanetworkopen.2022.30439.
3
Reproductive history and progressive multiple sclerosis risk in women.
女性的生殖史与进展型多发性硬化症风险
Brain Commun. 2020 Nov 17;2(2):fcaa185. doi: 10.1093/braincomms/fcaa185. eCollection 2020.
4
Therapeutic strategies in childhood multiple sclerosis.儿童多发性硬化症的治疗策略。
Ther Adv Neurol Disord. 2010 Jul;3(4):217-28. doi: 10.1177/1756285610371251.
5
Clinical and pharmacological aspects of inflammatory demyelinating diseases in childhood: an update.儿童炎性脱髓鞘疾病的临床和药理学方面:最新进展。
Curr Neuropharmacol. 2010 Jun;8(2):135-48. doi: 10.2174/157015910791233141.
6
Pediatric multiple sclerosis.小儿多发性硬化症
NeuroRx. 2006 Apr;3(2):264-75. doi: 10.1016/j.nurx.2006.01.011.